Urgent challenges in implementing live attenuated influenza vaccine.

Singanayagam, Anika; Zambon, Maria; Lalvani, Ajit; Barclay, Wendy

Singanayagam, Anika; Zambon, Maria; Lalvani, Ajit; Barclay, Wendy.

Affiliation

Singanayagam A; Department of Medicine, Imperial College, London, UK; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College, London, UK.
Zambon M; Virus Reference Department, National Infection Service, Public Health England, Colindale, London, UK; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College, London, UK.
Lalvani A; National Heart and Lung Institute, Imperial College, London, UK; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College, London, UK.
Barclay W; Department of Medicine, Imperial College, London, UK; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College, London, UK. Electronic address: w.barclay@imperial.ac.uk.

Lancet Infect Dis ; 18(1): e25-e32, 2018 01.

Article in En | MEDLINE | ID: mdl-28780285

Subject(s)

Influenza Vaccines/administration & dosage; Influenza Vaccines/immunology; Influenza, Human/prevention & control; Influenza, Human/virology; Orthomyxoviridae/immunology; Global Health; Health Policy; Humans; Influenza, Human/epidemiology; Treatment Outcome; Vaccines, Attenuated/administration & dosage; Vaccines, Attenuated/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orthomyxoviridae / Influenza Vaccines / Influenza, Human Type of study: Prognostic_studies Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2018 Document type: Article Affiliation country: United kingdom Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google